Live feed
Filing
SCHEDULE 13G
SCHEDULE 13G0001193805-25-000194·Applied Therapeutics, Inc.
Schedule 13G ownership disclosure
APPLIED THERAPEUTICS INC
Common Stock, par value $0.0001 per share · CUSIP: 03828A101
Event date: 2024-12-31
- Filing-level shares
- 8,769,640.00
- Percent of class
- 7.54%
- Schonfeld Strategic Advisors LLC
Shares: 8,769,640.00 · Class: 7.54%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001193805-25-000194
- Form type
- SCHEDULE 13G
- Filer
- Applied Therapeutics, Inc.
- CIK
- CIK 1697532
- Filed
- Feb 14, 2025
- Reporting period
- Dec 31, 2024
- Description
- Schedule 13G beneficial ownership